INOTEK PHARMACEUTICALS CORP's ticker is ITEK and the CUSIP is 45780V102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $2,548,000 | -55.8% | 976,300 | +3.2% | 0.00% | -100.0% |
| Q4 2016 | $5,769,000 | -35.2% | 945,781 | +0.7% | 0.00% | -50.0% |
| Q3 2016 | $8,902,000 | +64.2% | 939,081 | +28.9% | 0.00% | +100.0% |
| Q2 2016 | $5,420,000 | +0.5% | 728,433 | -0.1% | 0.00% | 0.0% |
| Q1 2016 | $5,394,000 | -35.2% | 728,933 | -0.8% | 0.00% | -50.0% |
| Q4 2015 | $8,328,000 | +18.1% | 735,063 | -2.0% | 0.00% | 0.0% |
| Q3 2015 | $7,050,000 | – | 749,963 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Devon Park Associates, LLC | 3,243,709 | $36,751,000 | 100.00% |
| RHO CAPITAL PARTNERS INC | 2,627,790 | $29,773,000 | 10.24% |
| Private Capital Advisors, Inc. | 341,000 | $3,864,000 | 1.67% |
| NEXTHERA CAPITAL LP | 42,000 | $476,000 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 360,000 | $4,079,000 | 0.60% |
| SENZAR ASSET MANAGEMENT, LLC | 309,600 | $3,507,768,000 | 0.39% |
| Graticule Asia Macro Advisors LLC | 148,000 | $1,676,000 | 0.27% |
| FT Options LLC | 26,421 | $299,000 | 0.22% |
| EAM Investors, LLC | 128,911 | $1,461,000 | 0.19% |
| Tekla Capital Management LLC | 425,000 | $4,815,000 | 0.18% |